Cormorant Asset Management, LP - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 72 filers reported holding CARDIFF ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q2 2021$637,000
-54.1%
95,720
-36.2%
0.02%
-29.0%
Q1 2021$1,389,000
-48.5%
150,0000.0%0.03%
-51.6%
Q4 2020$2,699,000
+8.7%
150,000
-14.3%
0.06%
-32.6%
Q3 2020$2,483,000175,0000.10%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
CAXTON CORP 2,522,083$15,158,00012.39%
Octagon Capital Advisors LP 982,753$5,906,0001.15%
Altium Capital Management LP 337,000$2,025,0000.56%
ACT CAPITAL MANAGEMENT, LLC 102,500$616,0000.44%
Eventide Asset Management 1,670,399$10,039,0000.13%
Artal Group S.A. 750,000$4,508,0000.12%
Aquatic Capital Management LLC 8,000$48,0000.09%
ELKHORN PARTNERS LIMITED PARTNERSHIP 17,300$104,0000.06%
Anson Funds Management LP 69,381$417,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 170,447$1,024,0000.02%
View complete list of CARDIFF ONCOLOGY INC shareholders